OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, et al.
Clinical & Experimental Immunology (2020) Vol. 204, Iss. 1, pp. 14-31
Open Access | Times Cited: 24

Showing 24 citing articles:

Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Amirata Mohseni, Fatemeh Salehi, Samaneh Rostami, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b)
Lixin Zhou, Jiamei Yang, Kuojun Zhang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 816-837
Closed Access | Times Cited: 9

Harnessing IL-27: challenges and potential in cancer immunotherapy
Ali Heidarnejad maleki, Mansour Rajabivahid, Elnaz Khosh, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity
Jason Chekmarev, Mahan Gholam Azad, Des R. Richardson
Cells (2021) Vol. 10, Iss. 9, pp. 2382-2382
Open Access | Times Cited: 42

Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease
Lidong Wang, Xiaodan Sun, Jingni He, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33

Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets
Vladimir Laletin, P Bernard, Cathy Costa Da Silva, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e005845-e005845
Open Access | Times Cited: 14

Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
A. Awan, Maryiam Jama Ali Osman, Omar M. Khan
Cells (2025) Vol. 14, Iss. 2, pp. 69-69
Open Access

Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access

Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
G. Ahmad, Samaneh Nouri, Amirhossein Mohammad Gholian, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118071-118071
Closed Access

Epigenetic and Post-Translational Modifications in Ferroptosis Regulation and Hepatocellular Carcinoma: New Frontiers in Therapeutic Targeting
Soheil Bolandi, Samaneh Dodge, Zahra Zahed, et al.
Pathology - Research and Practice (2025), pp. 155991-155991
Closed Access

Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy
Xiuqi Hu, Erdong Li, Yangguo Zhou, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 102, pp. 117677-117677
Closed Access | Times Cited: 3

AXL/Gas6 signaling mechanisms in the hypothalamic-pituitary-gonadal axis
Pardis Mohammadzadeh, Gregory C. Amberg
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6

CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells
Tahereh Mohammadian, Miso Kim, Ralph Sinn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16065-16065
Open Access | Times Cited: 5

Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential
Darmadi Darmadi, Raed Obaid Saleh, Enwa Felix Oghenemaro, et al.
Cell Biology International (2024)
Closed Access | Times Cited: 1

Involvement of the E3 ubiquitin ligase Cblb in host defense and evaluation of transcriptome during Trueperella pyogenes infection
Ting Huang, Zheng Lv, Kai Cui, et al.
Microbes and Infection (2023) Vol. 25, Iss. 5, pp. 105104-105104
Open Access | Times Cited: 2

Bactericidal Antibody Responses to Meningococcal Recombinant Outer Membrane Proteins
Ming Zhu, Yunqing Sun
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 7, pp. 1419-1424
Open Access

1025 GRC 65327, a novel small molecule selective Cbl-b inhibitor for solid tumors
Sachin S. Chaudhari, Vidya G. Kattige, Murugan Chinnapattu, et al.
Regular and Young Investigator Award Abstracts (2024), pp. A1146-A1146
Open Access

Expert opinion on therapeutic patents - manuscript ID EOTP-2024-ST-0024 has been submitted online
Riccardo Fusco, Zeinab Saedi, Imma Capriello, et al.
Expert Opinion on Therapeutic Patents (2024), pp. 1-10
Open Access

Targeting Ubiquitin–Proteasome System (UPS) in Treating Osteoarthritis
Pooi‐Fong Wong, Tunku Kamarul
European Journal of Pharmacology (2024), pp. 177237-177237
Closed Access

Enzyme Inhibitors from Gorgonians and Soft Corals
Andrea Córdova-Isaza, Sofía Jiménez-Mármol, Yasel Guerra, et al.
Marine Drugs (2023) Vol. 21, Iss. 2, pp. 104-104
Open Access | Times Cited: 1

E3 ubiquitin ligase components in GtoPdb v.2023.3
Elena Faccenda, Robert Layfield
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 3
Open Access

Page 1

Scroll to top